Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.8B | 7.2B | 7.1B | 6.4B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 2.0B | 1.9B | 1.8B | 1.7B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.4B | 2.0B | 2.1B | 1.8B |
| Tax provision | 611.2M | 524.9M | 540.5M | 456.2M |
| Net income | 1.8B | 1.5B | 1.6B | 1.3B |
| Basic EPS | — | 4.8 | 5.0 | 4.2 |
| Diluted EPS | — | 4.8 | 4.9 | 4.2 |
| Basic average shares | — | 313.5M | 313.4M | 312.8M |
| Diluted average shares | — | 316.2M | 316.0M | 315.8M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |